Inventor · disambiguated record
Stephen N. Greszler
Also filed as: GRESZLER STEPHEN N
7 granted patents·7 pending applications·78 citations·filing 2015–2021
84Inventor score
Top patents by PatentIndex Score
14 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0294US10138227B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2017·Granted Nov 27, 2018·31 cites·29 claims
- 0391US9642831B2Substituted chromanes and method of useABBVIE S Á R L·Filed 2015·Granted May 9, 2017·7 cites·69 claims
- 0484US10399940B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted Sep 3, 2019·4 cites·21 claims
- 0582US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 0679US9840513B2Substituted tricyclics and method of useABBVIE S À R L·Filed 2016·Granted Dec 12, 2017·3 cites·68 claims
- 0778US10604515B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2018·Granted Mar 31, 2020·1 cites·2 claims
- 0863US2019127356A1Substituted Chromanes and Method of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 0960US2017190693A1Substituted chromanes and method of useABBVIE S À R L·Filed 2017·Application pending·0 cites
- 1057US2019135827A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 1155US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 1254US2018037587A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2017·Application pending·0 cites
- 1354US2022213092A1Bicyclic pyrazole bruton's tyrosine kinase inhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 1453US2019315687A1Substituted Pyrrolidines and Methods of UseABBVIE SARL·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →